Harris Kaplan Featured on Citeline's In Vivo Podcast: Why Product Demand, Not Coverage, Drives Formulary Power

Harris Kaplan, Managing Partner of Litmys and author of Approval Is Not Adoption, joined Citeline's In Vivo podcast for a discussion about the relationship between product demand, formulary access, and the evolving influence of pharmacy benefit managers (PBMs) on pharmaceutical commercialization. Topspin and Why Product Demand, Not Coverage, Drives Formulary Power
The conversation explores why formulary coverage alone does not guarantee commercial success and how meaningful demand from physicians and patients can influence a product's negotiating position with PBMs. Rather than viewing market access as the primary driver of adoption, manufacturers must consider how product differentiation and customer preferences shape demand and ultimately influence payer decisions.
The discussion reinforces a central principle of Litmys' approach to commercialization: understanding what drives real-world adoption is essential to developing effective market access strategies and building realistic expectations for product performance.
Listen to or watch the full episode: Citeline In Vivo | Spotify | Apple


